178 related articles for article (PubMed ID: 19205519)
1. Impact of tumour characteristic and treatment modality on the local recurrence and the survival in patients with oral squamous cell carcinoma.
Kos M; Łuczak K; Brusco D; Engelke W
Otolaryngol Pol; 2008; 62(6):722-6. PubMed ID: 19205519
[TBL] [Abstract][Full Text] [Related]
2. [Outcome of surgical and adjuvant radiotherapy treatment of T3-T4 squamous cell carcinoma of the floor of the mouth: evaluation of oncological control and treatment related morbidity].
Hitter A; Soriano E; Bettega G; Karkas A; Reyt E; Righini CA
Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):155-62. PubMed ID: 18323327
[TBL] [Abstract][Full Text] [Related]
3. The relevance of surgical margins in clinically early oral squamous cell carcinoma.
Bajwa MS; Houghton D; Java K; Triantafyllou A; Khattak O; Bekiroglu F; Schache AG; Brown JS; McCaul JA; Rogers SN; Lowe D; McMahon J; Shaw RJ
Oral Oncol; 2020 Nov; 110():104913. PubMed ID: 32711167
[TBL] [Abstract][Full Text] [Related]
4. The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas.
Wenzel S; Sagowski C; Kehrl W; Metternich FU
Eur Arch Otorhinolaryngol; 2004 May; 261(5):270-5. PubMed ID: 14504863
[TBL] [Abstract][Full Text] [Related]
5. Oral maxillary squamous carcinoma: an indication for neck dissection in the clinically negative neck.
Montes DM; Carlson ER; Fernandes R; Ghali GE; Lubek J; Ord R; Bell B; Dierks E; Schmidt BL
Head Neck; 2011 Nov; 33(11):1581-5. PubMed ID: 21990223
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.
Jerjes W; Upile T; Petrie A; Riskalla A; Hamdoon Z; Vourvachis M; Karavidas K; Jay A; Sandison A; Thomas GJ; Kalavrezos N; Hopper C
Head Neck Oncol; 2010 Apr; 2():9. PubMed ID: 20406474
[TBL] [Abstract][Full Text] [Related]
7. Oncologic safety of the submental flap for reconstruction in oral cavity malignancies.
Howard BE; Nagel TH; Donald CB; Hinni ML; Hayden RE
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):558-62. PubMed ID: 24503306
[TBL] [Abstract][Full Text] [Related]
8. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
9. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients.
González-García R; Naval-Gías L; Román-Romero L; Sastre-Pérez J; Rodríguez-Campo FJ
Head Neck; 2009 Sep; 31(9):1168-80. PubMed ID: 19408289
[TBL] [Abstract][Full Text] [Related]
10. Survival after free flap reconstruction in patients with advanced oral squamous cell carcinoma.
de Vicente JC; Rodríguez-Santamarta T; Rosado P; Peña I; de Villalaín L
J Oral Maxillofac Surg; 2012 Feb; 70(2):453-9. PubMed ID: 21684658
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome?
Sklenicka S; Gardiner S; Dierks EJ; Potter BE; Bell RB
J Oral Maxillofac Surg; 2010 Jun; 68(6):1270-5. PubMed ID: 20347201
[TBL] [Abstract][Full Text] [Related]
12. Elective neck dissection for carcinomas of the oral cavity: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive necks.
Zbären P; Nuyens M; Caversaccio M; Stauffer E
Am J Surg; 2006 Jun; 191(6):756-60. PubMed ID: 16720144
[TBL] [Abstract][Full Text] [Related]
13. [The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma].
Hundsdorfer B; Zeilhofer HF; Bock KP; Dettmar P; Schmitt M; Horch HH
Mund Kiefer Gesichtschir; 2004 May; 8(3):173-9. PubMed ID: 15138855
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma].
Hundsdorfer B; Zeilhofer HF; Bock KP; Dettmar P; Schmitt M; Horch HH
Mund Kiefer Gesichtschir; 2004 May; 8(3):180-90. PubMed ID: 15138856
[TBL] [Abstract][Full Text] [Related]
15. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
16. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
Matoscevic K; Graf N; Pezier TF; Huber GF
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
[TBL] [Abstract][Full Text] [Related]
17. Relationship between postoperative complications and survival after free flap reconstruction for oral cavity squamous cell carcinoma.
Ch'ng S; Choi V; Elliott M; Clark JR
Head Neck; 2014 Jan; 36(1):55-9. PubMed ID: 23559547
[TBL] [Abstract][Full Text] [Related]
18. Elective neck dissection in early-stage oral squamous cell carcinoma--does it influence recurrence and survival?
Capote A; Escorial V; Muñoz-Guerra MF; Rodríguez-Campo FJ; Gamallo C; Naval L
Head Neck; 2007 Jan; 29(1):3-11. PubMed ID: 17103411
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of histological features in oral squamous cell carcinoma.
Larsen SR; Johansen J; Sørensen JA; Krogdahl A
J Oral Pathol Med; 2009 Sep; 38(8):657-62. PubMed ID: 19563504
[TBL] [Abstract][Full Text] [Related]
20. [Neck dissection for stage N0 oral cavity carcinoma].
Jegoux F; Cazé A; Mohr E; Godey B; Le Clech G
Ann Otolaryngol Chir Cervicofac; 2006 Nov; 123(5):221-6. PubMed ID: 17185919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
